About 1 in 2 albuterol solutions are in shortage two months after Akorn Operating Co., a Gurnee, Ill.-based drugmaker, closed. 

Drug shortages are at 10-year high so far in 2023, according to the American Society of Health-System Pharmacists.

A new bioengineered drug candidate demonstrated superior performance to a standard antibiotic at treating mice infected with Staphylococcus aureus, according to results from early testing published April 24 in Cell Host & Microbe. 

Eli Lilly has entered into a phase three clinical trial for its tirzepatide drug, also known as Mounjaro, to evaluate its efficacy at improving weight loss outcomes for patients experiencing obesity.

In compliance with the FDA and European regulators, Foghorn Therapeutics paused research testing its investigative cancer therapy, FHD-609, the Cambridge, Mass.-based biotech company said April 24. 

Patients who take Ozempic, a diabetes medication popularized for its off-label use as a weight-loss drug, are reporting strange outcomes. 

Desi Kotis, PharmD, the chief pharmacy executive at the University of California San Francisco Health, told Becker's hospital pharmacy teams should continue focusing on grassroots efforts to ensure patients know their pharmacists and pharmacy technicians. 

Mark Cuban launched his online drug business, Mark Cuban Cost Plus Drug Co., in January 2022 with the plan to "f— up" the industry. He hasn't done that yet, he told Becker's in early April. 

The Inflation Reduction Act is spurring pharma companies into mergers and acquisitions because of the "approaching patent cliff" in 2026, according to a report Moody's published April 17. 

Since 2015, at least 20 drugs have been in and out of shortage, according to the American Society of Health-System Pharmacists' drug supply database. 

Blue Cross and Blue Shield of Texas announced the launch of a mobile pharmacy benefit app, "MyBlueRxTX."

One day after launching a network of independent pharmacies across four states, Mark Cuban Cost Plus Drug Co. tapped RevSpring to handle the drug company's payments. 

With the exception of critical cases, during the coronavirus pandemic the FDA mostly halted the inspections of overseas drug manufacturing sites. Now, long after they have resumed, the FDA is still very much behind schedule. In 2022, the agency only inspected 6 percent of overseas facilities, according to an investigation from ProPublica.

The CDC backed changes to the COVID-19 vaccination schedule on April 19, simplifying recommendations and including a second bivalent booster authorized by the FDA April 18 for senior populations and people who are immunocompromised.

HHS released a COVID-19 vaccine and treatment access program April 18 in anticipation of the end of the pandemic's public health emergency, which is expected to expire May 11. 

As more pharmacy employees report burnout, 84 percent of hospitals are working to reverse the growing trend, according to a national study conducted by the American Society of Health-System Pharmacists.

Many people taking popular weight loss drugs such as Ozempic and Wegovy are reporting an unexpected side effect: having bizarre and vivid dreams, The Wall Street Journal reported April 18. 

Mark Cuban is creating an independent pharmacy network to "serve patients more widely" after pitching the idea to local pharmacy owners in February. 

The Institute for Clinical and Economic Review found lecanemab, Eisai and Biogen's recently approved Alzheimer's drug, failed to "demonstrate a net health benefit" when compared to supportive care for adults with early Alzheimer's disease. 

Canton, Ohio-based Cleveland Clinic Mercy Hospital donated an unused office building to Beacon Charitable Pharmacy, a nonprofit pharmacy that provides low-cost prescription medication.